zalcitabine has been researched along with Anemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buckley, LA; Collins, BJ; Foley, JF; Giles, HD; Heath, JE; May, RD; Rao, GN | 1 |
Stevens, TP; Watson, WJ; Weinberg, GA | 1 |
Sommadossi, JP; Weidner, DA | 1 |
3 other study(ies) available for zalcitabine and Anemia
Article | Year |
---|---|
Carcinogenicity of 2',3'-dideoxycytidine in mice.
Topics: Anemia; Animals; Anti-HIV Agents; Atrophy; Body Weight; Carcinogenicity Tests; CD4-CD8 Ratio; Female; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Sex Factors; Species Specificity; Thymus Gland; Thymus Neoplasms; Time Factors; Tumor Suppressor Protein p53; Zalcitabine | 1996 |
Profound anemia in a newborn infant of a mother receiving antiretroviral therapy.
Topics: Adult; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Newborn; Lamivudine; Leukocyte Count; Male; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Viral Load; Zalcitabine; Zidovudine | 1998 |
3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
Topics: Anemia; Butyrates; Butyric Acid; Dose-Response Relationship, Drug; Globins; Hemoglobins; Humans; Leukemia, Erythroblastic, Acute; Protein Biosynthesis; Transcription, Genetic; Tumor Cells, Cultured; Zalcitabine; Zidovudine | 1990 |